Corient Private Wealth
TENX icon

Corient Private Wealth’s Tenax Therapeutics TENX Stock Holding History

Corient Private Wealth’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Hold
12,388
– – ﹤0.01% 2835
2026
Q1 		$198K Hold
12,388
– – ﹤0.01% 2573
2025
Q4 		$151K Buy
+12,388
New +$108K ﹤0.01% 2475
2024
Q1 		– Sell
-2,387
Closed -$52.4K – 2367
2023
Q4 		$52.4K Sell
2,387
-6
-0.3% -$144 ﹤0.01% 2195
2023
Q3 		$56.4K Hold
2,393
– – ﹤0.01% 2069
2023
Q2 		$57.4K Hold
2,393
– – ﹤0.01% 2012
2023
Q1 		$89K Buy
+2,393
New +$250K ﹤0.01% 1899

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Corient Private Wealth's TENX Position: Q2 2026 in Review

Corient Private Wealth held its Tenax Therapeutics (TENX) position steady in Q2 2026 at 12,388 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Corient Private Wealth first reported a position in TENX in Q1 2023 and has held it in 7 quarters since. The position peaked at $198K in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Corient Private Wealth held 12,388 shares of Tenax Therapeutics worth $180K as of Q2 2026.
  • Corient Private Wealth left its Tenax Therapeutics share count unchanged in Q2 2026.
  • Tenax Therapeutics made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2835 holding.
  • Corient Private Wealth first reported a position in Tenax Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • Corient Private Wealth's Tenax Therapeutics position peaked at $198K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.